Skip to main content

Table 1 Participants characteristics

From: Should knee extension strength testing be implemented as a screening test for identifying probable and confirmed sarcopenia in older T2DM patients?

Variables Men (n = 40) Women (n = 60) Total (n = 100)
Anthropometric measurements
 Age (years) 70.5 ± 4.2 70.4 ± 5.0 70.5 ± 4.6
 height (cm) 172 ± 6.1 158 ± 4.5 1.63 ± 0.1
 Weight (kg) 94.8 ± 16.4 78.3 ± 14.2 84.7 ± 17.3
 WC (cm) 113.5 ± 13.7 106.6 ± 13.6 109.2 ± 14
 Body Mass Index (kg/m2) 31.1 ± 5.6 31.4 ± 6.1 31.6 ± 5.9
 Lean body mass leg (kg) 9.18 ± 1.35 6.3 ± 0.87 7.35 ± 1.7
 Lean body mass arm (kg) 3.64 ± 0.53 2.37 ± 0.46 2.84 ± 0.7
 ASMI (kg/m2) 8.55 ± 0.9 6.90 ± 0.9 7.52 ± 1.2
 ASM (kg) 25.3 ± 3.36 17.1 ± 4.9 20.36 ± 4.2
 Fat mass (%) 36.4 ± 6.7 43.8 ± 5.8 40.8 ± 6.2
Strength and functional measurements
 KES (kg) 37.58 ± 8.0 24.0 ± 5.6 29.2 ± 9.4
 KES/weight (kg/kg) 0.39 ± 0.07 0.31 ± 0.06 0.34 ± 0.1
 HGS (kg) 40.06 ± 6.83 24.97 ± 4.3 31 ± 9.2
 HGS/weight (kg/kg) 0.44 ± 0.1 0.33 ± 0.07 0.37 ± 0.1
Clinical Data
 Obesity: BMI > 30 (%) 65.0 55.0 59
 Obesity: WC > 102 cm men (%) > 88 cm women (%) 87.5 96.6 93
 Obesity: >  1 SD than mean reference values of % fat (%) 1 77.5 65 70
 Diabetes duration (years) 12.3 ± 10.1 13.7 ± 8.8 13.37 ± 9.4
 Diabetes> 10 years (%) 58.7 67.8 64
 HbA1c (%) 7.63 ± 1.3 7.34 ± 0.9 7.46 ± 1.14
 Neuropathy (%) 12.5 17.0 15.2
 Nephropathy (%) 15.0 6.8 10.1
 Retinopathy (%) 7.7 8.8 8.3
 IHD (%) 10.6 5.3 7.4
 CHF (%) 5.2 2
 Hypertension (%) 56.5 54.3 55.2
 Statin use (%) 64.1 52.6 57.1
 Polypharmacy (> 8 med’s) 25 30 28
 Low vitamin D < 25 ng/mL (%) 43.3 43.6 43.4
Physical performance
 Gait speed (m/s’) 1.09 ± 0.2 1.08 ± 0.18 1.08 ± 0.19
 Timed up & go (s’) 10.6 ± 1.7 10.87 ± 2.16 10.76 ± 2.0
 Chair stands 30 s’ 11.28 ± 1.8 10.6 ± 2.9 10.99 ± 2.35
 2 Min’ walk Test (m’) 172 ± 25.9 158.37 ± 23.65 163.7 ± 25.3
  1. Abbreviations: ASM Appendicular Skeletal Mass, ASMI Appendicular Skeletal Mass Index, BMI Body Mass Index, CHF Chronic Heart Failure, HGS Hand Grip Strength, IHD Ischemic Heart Disease, KES Knee Extension Strength, WC Waist Circumference
  2. 1-According to normative data published [35]